MSL
MDCO

Mackay Shields LLC’s Medicines Co MDCO Stock Holding History

Mackay Shields LLC’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-46,100
Closed -$3.92M – 1562
2019
Q4 		$3.92M Sell
46,100
-5,800
-11% -$387K 0.03% 569
2019
Q3 		$2.6M Buy
+51,900
New +$2.07M 0.02% 791

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Mackay Shields LLC's MDCO Position: Q1 2020 in Review

Mackay Shields LLC sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 46,100 shares — an estimated $3.92M sold.

Mackay Shields LLC first reported a position in MDCO in Q3 2019 and held it in 2 quarters. The position peaked at $3.92M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Mackay Shields LLC reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Mackay Shields LLC sold 46,100 Medicines Co shares in Q1 2020, an estimated $3.92M.
  • Mackay Shields LLC first reported a position in Medicines Co in Q3 2019 and held it in 2 quarters.
  • Mackay Shields LLC's Medicines Co position peaked at $3.92M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Mackay Shields LLC's 13F filing for Q1 2020, filed 8 May 2020.